ERBB2 and breast carcinoma: BCAT1 expressed in the cytoplasm was highly expressed in human epidermal growth factor receptor 2 positive (HER2+) breast cancer, while BCAT2 expressed in the mitochondria tended to be highly expressed in estrogen receptor-positive (ER+) breast cancer.